HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief

This article was originally published in The Rose Sheet

Executive Summary

Expected guidance on lead in cosmetics is still under development, CFSAN says; Avon finalizes settlement with SEC over China bribery charges. More news in brief.

You may also be interested in...

In Brief: N.J. Bans Microbeads; Prestige Device Sales; Direct Sellers Merge

New Jersey becomes the second state that will prohibit the production and sale of microbeads, as Gov. Chris Christie signs into law a bill that closely follow’s Illinois’ industry-backed legislation. More news in brief.

Analysts On Avon Buyout Rumor: Easier Turnaround ‘Outside The Public Eye’?

Morningstar analyst Eric Lash speculates that the “drastic actions necessary to right Avon’s ship” may be more easily implemented if private equity firm TPG Capital added the direct seller to its portfolio, which already includes Avon Japan. The investment community weighs in on an unconfirmed report that Avon is exploring a potential buyout.

Congressional Appropriators Urge FDA Action On Cosmetic Lead Limits

House and Senate committee reports on proposed FDA appropriations for fiscal 2015 direct the agency to respond to a nearly three-year-old petition requesting an agency-sanctioned limit on trace lead in lipstick and other cosmetics. Appropriators set a March 15, 2015 deadline for FDA’s response.

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts